Cardiomyopathy Trial, Recruiting (NCT07006493)

Cardiomyopathy Trial, Recruiting NCT07006493 Sponsor: SuZhou Sinus Medical Technologies Co.,Ltd Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT07006493 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old (any sex)
You have been diagnosed with obstructive hypertrophic cardiomyopathy (a condition where the heart muscle is thickened and blocks blood flow)
You have noticeable symptoms such as shortness of breath, chest pain, tiredness, heart palpitations, or fainting
Your symptoms and heart measurements (checked by ultrasound) meet a certain level of severity — confirm exact thresholds with trial site
The wall of your heart is thickened to a specific degree, but not excessively so (confirm exact measurements with trial site)
You are not a suitable candidate for heart surgery, or you have chosen not to have surgery
You are willing to give your consent and attend all required follow-up appointments

Who may not be able to join:

You have no symptoms, or your type of heart condition does not cause a blockage in blood flow
The thickened wall of your heart is very large (above a certain measurement — confirm with trial site)
The shape or structure of your heart's mitral valve is not suitable for the procedure, as decided by the medical team
You are considered at high risk of sudden cardiac death and need a specific type of implanted heart device (ICD)
You have a certain type of electrical conduction problem in your heart detected at screening (confirm with trial site)
You have an active heart infection, heart inflammation, a heart tumour, or a blood clot inside your heart
Your heart anatomy makes a certain type of surgical access not possible (confirm with trial site)
You have an artificial mechanical heart valve or have previously had your aortic valve replaced
You have severe heart failure with a significantly reduced pumping function
You have had a major heart event (such as a heart attack, cardiac arrest, or heart failure hospitalisation) in the last 6 months
You have another serious heart structural problem that requires surgery
You have previously had a procedure to reduce the thickness of your heart wall, or you have a pacemaker
You have a condition causing the sac around your heart to be stiff, or a significant heart defect present from birth
You have a bleeding disorder or cannot safely take blood-thinning medication
Your liver is not functioning well, based on specific blood test results (confirm with trial site)
Your kidneys are not functioning well, based on specific blood test results, or you are on dialysis
You are pregnant, breastfeeding, or planning to become pregnant within 6 months after the procedure
Your life expectancy is less than 12 months
You have taken part in another medical research study within the last 30 days (or within a certain timeframe based on another study's medication — confirm with trial site)
The medical team has concerns about your ability to follow the study requirements, or feels the trial is not appropriate for you
You are unable to have a cardiac MRI scan — for example, due to having an ICD, an allergy to the contrast dye used, or claustrophobia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Changshen Ma, Doctor, Capital Medical University Affiliated Beijing Anzhen Hospital

Phone: +86 18121015668

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07006493

Sponsor: SuZhou Sinus Medical Technologies Co.,Ltd

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +86 18121015668

More information: https://clinicaltrials.gov/study/NCT07006493

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old (any sex)
You have been diagnosed with obstructive hypertrophic cardiomyopathy (a condition where the heart muscle is thickened and blocks blood flow)
You have noticeable symptoms such as shortness of breath, chest pain, tiredness, heart palpitations, or fainting
Your symptoms and heart measurements (checked by ultrasound) meet a certain level of severity — confirm exact thresholds with trial site
The wall of your heart is thickened to a specific degree, but not excessively so (confirm exact measurements with trial site)
You are not a suitable candidate for heart surgery, or you have chosen not to have surgery
You are willing to give your consent and attend all required follow-up appointments

Who may not be able to join:

You have no symptoms, or your type of heart condition does not cause a blockage in blood flow
The thickened wall of your heart is very large (above a certain measurement — confirm with trial site)
The shape or structure of your heart's mitral valve is not suitable for the procedure, as decided by the medical team
You are considered at high risk of sudden cardiac death and need a specific type of implanted heart device (ICD)
You have a certain type of electrical conduction problem in your heart detected at screening (confirm with trial site)
You have an active heart infection, heart inflammation, a heart tumour, or a blood clot inside your heart
Your heart anatomy makes a certain type of surgical access not possible (confirm with trial site)
You have an artificial mechanical heart valve or have previously had your aortic valve replaced
You have severe heart failure with a significantly reduced pumping function
You have had a major heart event (such as a heart attack, cardiac arrest, or heart failure hospitalisation) in the last 6 months
You have another serious heart structural problem that requires surgery
You have previously had a procedure to reduce the thickness of your heart wall, or you have a pacemaker
You have a condition causing the sac around your heart to be stiff, or a significant heart defect present from birth
You have a bleeding disorder or cannot safely take blood-thinning medication
Your liver is not functioning well, based on specific blood test results (confirm with trial site)
Your kidneys are not functioning well, based on specific blood test results, or you are on dialysis
You are pregnant, breastfeeding, or planning to become pregnant within 6 months after the procedure
Your life expectancy is less than 12 months
You have taken part in another medical research study within the last 30 days (or within a certain timeframe based on another study's medication — confirm with trial site)
The medical team has concerns about your ability to follow the study requirements, or feels the trial is not appropriate for you
You are unable to have a cardiac MRI scan — for example, due to having an ICD, an allergy to the contrast dye used, or claustrophobia

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

SuZhou Sinus Medical Technologies Co.,Ltd

Registry

ClinicalTrials.gov

Start date

20 July 2025

Est. completion

30 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Treatment Effectiveness Rate at 6 Months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov